Johannes Blom1, Sini Kilpeläinen2, Rolf Hultcrantz3, Sven Törnberg4. 1. Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden johannes.blom@ki.se. 2. Regional Cancer Centre Stockholm Gotland, Sweden. 3. Division of Gastroenterology and Hepatology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden. 4. Department of Oncology-Pathology, Karolinska Institutet and Regional Cancer Centre Stockholm Gotland, Sweden.
Abstract
OBJECTIVE: To evaluate compliance by age, gender, and screening round in the population based Stockholm/Gotland colorectal cancer screening programme. METHODS: All individuals aged between 60 and 69 living in the counties of Stockholm and Gotland (Sweden) have, since 2008, successively been included in a colorectal cancer screening programme using biennial faecal occult blood tests (Hemoccult®). Personal invitations including test kits have been sent to home addresses, and individuals with a positive test result have been called to a defined clinic for an assessment colonoscopy. Descriptive statistics have been used to evaluate different aspects of compliance. RESULTS: Over the five-year period 2008-2012, more than 200,000 individuals from nine different birth cohorts have been invited, with a compliance rate of approximately 60%, which increased by age, female gender, and subsequent screening round. In total, 4,300 individuals (2.1%) with positive tests were referred to assessment colonoscopy, where 213 colorectal cancers were diagnosed. The compliance with the follow-up colonoscopies varied by year, and ranged from 85.6-92.4%. CONCLUSION: The strong organization of the programme contributed to a high compliance rate, that increased by screening round. The lower participation rate among men and among individuals at younger ages needs further attention.
OBJECTIVE: To evaluate compliance by age, gender, and screening round in the population based Stockholm/Gotland colorectal cancer screening programme. METHODS: All individuals aged between 60 and 69 living in the counties of Stockholm and Gotland (Sweden) have, since 2008, successively been included in a colorectal cancer screening programme using biennial faecal occult blood tests (Hemoccult®). Personal invitations including test kits have been sent to home addresses, and individuals with a positive test result have been called to a defined clinic for an assessment colonoscopy. Descriptive statistics have been used to evaluate different aspects of compliance. RESULTS: Over the five-year period 2008-2012, more than 200,000 individuals from nine different birth cohorts have been invited, with a compliance rate of approximately 60%, which increased by age, female gender, and subsequent screening round. In total, 4,300 individuals (2.1%) with positive tests were referred to assessment colonoscopy, where 213 colorectal cancers were diagnosed. The compliance with the follow-up colonoscopies varied by year, and ranged from 85.6-92.4%. CONCLUSION: The strong organization of the programme contributed to a high compliance rate, that increased by screening round. The lower participation rate among men and among individuals at younger ages needs further attention.
Authors: Andrea N Burnett-Hartman; Shivan J Mehta; Yingye Zheng; Nirupa R Ghai; Dale F McLerran; Jessica Chubak; Virginia P Quinn; Celette Sugg Skinner; Douglas A Corley; John M Inadomi; Chyke A Doubeni Journal: Am J Prev Med Date: 2016-04-01 Impact factor: 5.043
Authors: Therese M-L Andersson; Paul W Dickman; Sandra Eloranta; Annika Sjövall; Mats Lambe; Paul C Lambert Journal: BMC Cancer Date: 2015-05-17 Impact factor: 4.430
Authors: Sonja Neumeyer; Xinwei Hua; Petra Seibold; Lina Jansen; Axel Benner; Barbara Burwinkel; Niels Halama; Sonja I Berndt; Amanda I Phipps; Lori C Sakoda; Robert E Schoen; Martha L Slattery; Andrew T Chan; Manish Gala; Amit D Joshi; Shuji Ogino; Mingyang Song; Esther Herpel; Hendrik Bläker; Matthias Kloor; Dominique Scherer; Alexis Ulrich; Cornelia M Ulrich; Aung K Win; Jane C Figueiredo; John L Hopper; Finlay Macrae; Roger L Milne; Graham G Giles; Daniel D Buchanan; Ulrike Peters; Michael Hoffmeister; Hermann Brenner; Polly A Newcomb; Jenny Chang-Claude Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-10-02 Impact factor: 4.090